Cargando…

Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)

BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambelli, Vanessa Olzon, Chioato, Lucimara, Gutierrez, Vanessa Pacciari, Ward, Richard John, Cury, Yara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303236/
https://www.ncbi.nlm.nih.gov/pubmed/28203248
http://dx.doi.org/10.1186/s40409-017-0099-6
_version_ 1782506671181922304
author Zambelli, Vanessa Olzon
Chioato, Lucimara
Gutierrez, Vanessa Pacciari
Ward, Richard John
Cury, Yara
author_facet Zambelli, Vanessa Olzon
Chioato, Lucimara
Gutierrez, Vanessa Pacciari
Ward, Richard John
Cury, Yara
author_sort Zambelli, Vanessa Olzon
collection PubMed
description BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, the amino acid residues that determine hyperalgesia and edema are unknown. The aim of this study was to characterize the structural determinants for the Lys49-PLA(2)-induced nociception and inflammation. METHODS: Scanning alanine mutagenesis in the active-site and C-terminal regions of BthTx-I has been used to study the structural determinants of toxin activities. The R118A mutant was employed as this substitution decreases PLA(2) myotoxicity. In addition, K115A and K116A mutants – which contribute to decrease cytotoxicity – and the K122A mutant – which decreases both myotoxicity and cytotoxicity – were also used. The H48Q mutant – which does not interfere with membrane damage or myotoxic activity – was used to evaluate if the PLA(2) catalytic site is relevant for the non-catalytic PLA(2)-induced pain and inflammation. Wistar male rats received intraplantar injections with mutant PLA(2). Subsequently, hyperalgesia and edema were evaluated by the paw pressure test and by a plethysmometer. Native and recombinant BthTx-I were used as controls. RESULTS: Native and recombinant BthTx-I induced hyperalgesia and edema, which peaked at 2 h. The R118A mutant did not induce nociception or edema. The mutations K115A and K116A abolished hyperalgesia without interfering with edema. Finally, the K122A mutant did not induce hyperalgesia and presented a decreased inflammatory response. CONCLUSIONS: The results obtained with the BthTx-I mutants suggest, for the first time, that there are distinct residues responsible for the hyperalgesia and edema induced by BthTx-I. In addition, we also showed that cytolytic activity is essential for the hyperalgesic effect but not for edematogenic activity, corroborating previous data showing that edema and hyperalgesia can occur in a non-dependent manner. Understanding the structure-activity relationship in BthTx-I has opened new possibilities to discover the target for PLA(2)-induced pain.
format Online
Article
Text
id pubmed-5303236
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53032362017-02-15 Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) Zambelli, Vanessa Olzon Chioato, Lucimara Gutierrez, Vanessa Pacciari Ward, Richard John Cury, Yara J Venom Anim Toxins Incl Trop Dis Research BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, the amino acid residues that determine hyperalgesia and edema are unknown. The aim of this study was to characterize the structural determinants for the Lys49-PLA(2)-induced nociception and inflammation. METHODS: Scanning alanine mutagenesis in the active-site and C-terminal regions of BthTx-I has been used to study the structural determinants of toxin activities. The R118A mutant was employed as this substitution decreases PLA(2) myotoxicity. In addition, K115A and K116A mutants – which contribute to decrease cytotoxicity – and the K122A mutant – which decreases both myotoxicity and cytotoxicity – were also used. The H48Q mutant – which does not interfere with membrane damage or myotoxic activity – was used to evaluate if the PLA(2) catalytic site is relevant for the non-catalytic PLA(2)-induced pain and inflammation. Wistar male rats received intraplantar injections with mutant PLA(2). Subsequently, hyperalgesia and edema were evaluated by the paw pressure test and by a plethysmometer. Native and recombinant BthTx-I were used as controls. RESULTS: Native and recombinant BthTx-I induced hyperalgesia and edema, which peaked at 2 h. The R118A mutant did not induce nociception or edema. The mutations K115A and K116A abolished hyperalgesia without interfering with edema. Finally, the K122A mutant did not induce hyperalgesia and presented a decreased inflammatory response. CONCLUSIONS: The results obtained with the BthTx-I mutants suggest, for the first time, that there are distinct residues responsible for the hyperalgesia and edema induced by BthTx-I. In addition, we also showed that cytolytic activity is essential for the hyperalgesic effect but not for edematogenic activity, corroborating previous data showing that edema and hyperalgesia can occur in a non-dependent manner. Understanding the structure-activity relationship in BthTx-I has opened new possibilities to discover the target for PLA(2)-induced pain. BioMed Central 2017-02-10 /pmc/articles/PMC5303236/ /pubmed/28203248 http://dx.doi.org/10.1186/s40409-017-0099-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zambelli, Vanessa Olzon
Chioato, Lucimara
Gutierrez, Vanessa Pacciari
Ward, Richard John
Cury, Yara
Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title_full Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title_fullStr Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title_full_unstemmed Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title_short Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
title_sort structural determinants of the hyperalgesic activity of myotoxic lys49-phospholipase a(2)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303236/
https://www.ncbi.nlm.nih.gov/pubmed/28203248
http://dx.doi.org/10.1186/s40409-017-0099-6
work_keys_str_mv AT zambellivanessaolzon structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2
AT chioatolucimara structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2
AT gutierrezvanessapacciari structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2
AT wardrichardjohn structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2
AT curyyara structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2